Carvedilol Tablet, Film Coated
Product Images NDC 68071-2230

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-2230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2230 8)

Carvedilol 12.5 mg film-coated tablets label by NuCare Pharmaceuticals, Inc. The label states 180 tablets per container and describes each tablet as round, white/off-white debossed with 'ZC41'. It includes warnings to keep out of reach of children, storage conditions of 68-77°F, and note that it is Rx only. Manufacturer is Cadila Healthcare Ltd, India.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of Carvedilol showing its molecular arrangement, including an indole ring connected to an alcohol, ether, amine, and methoxy phenyl groups.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A Kaplan-Meier survival curve comparing mortality percentages over 21 months between two groups: one receiving Carvedilol and the other a placebo. The graph shows mortality on the y-axis and months on the x-axis, with the Carvedilol group exhibiting lower mortality than the placebo group as time progresses.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot chart depicting hazard ratios for various subgroups, including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone usage. Each subgroup is represented with a point estimate and confidence interval, with a vertical line at hazard ratio 1.0 indicating no effect.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph showing percent mortality over a 24-month period comparing Carvedilol and placebo. Two lines depict mortality trends, with the placebo line consistently higher than the Carvedilol line, and a p-value of 0.03 noted on the graph.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart showing hazard ratios for various patient subgroups related to Carvedilol treatment outcomes. The subgroups include age, gender, randomization timing after myocardial infarction (MI), prior use of IV/oral beta blockers, Killip class, thrombolytic therapy, PTCA for MI, congestive heart failure (CHF) status, angina presence, hypertension, diabetes, heart rate, and systolic blood pressure levels. Each subgroup's hazard ratio is depicted with confidence intervals on a logarithmic scale from 0.4 to 1.3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.